JPH0692841A - Production of aerosol composition - Google Patents
Production of aerosol compositionInfo
- Publication number
- JPH0692841A JPH0692841A JP24638392A JP24638392A JPH0692841A JP H0692841 A JPH0692841 A JP H0692841A JP 24638392 A JP24638392 A JP 24638392A JP 24638392 A JP24638392 A JP 24638392A JP H0692841 A JPH0692841 A JP H0692841A
- Authority
- JP
- Japan
- Prior art keywords
- component
- oil
- aerosol composition
- skin
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000000443 aerosol Substances 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims abstract description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000003921 oil Substances 0.000 claims description 33
- 235000019198 oils Nutrition 0.000 claims description 33
- 239000011550 stock solution Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 7
- -1 fatty acid esters Chemical class 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000010775 animal oil Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229920002545 silicone oil Polymers 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- 206010040880 Skin irritation Diseases 0.000 abstract description 8
- 230000036556 skin irritation Effects 0.000 abstract description 8
- 231100000475 skin irritation Toxicity 0.000 abstract description 8
- 238000005191 phase separation Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 description 21
- 238000005238 degreasing Methods 0.000 description 10
- 239000003380 propellant Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 8
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001760 anti-analgesic effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 229960002389 glycol salicylate Drugs 0.000 description 3
- 239000003915 liquefied petroleum gas Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229940075894 denatured ethanol Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000005218 dimethyl ethers Chemical class 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はエアゾール組成物の製法
に関する。さらに詳しくは、たとえば化粧品、医薬品、
医薬部外品などに好適に使用しうるエアゾール組成物の
製法に関する。FIELD OF THE INVENTION The present invention relates to a method for producing an aerosol composition. More specifically, for example, cosmetics, pharmaceuticals,
The present invention relates to a method for producing an aerosol composition which can be suitably used for quasi drugs.
【0002】[0002]
【従来の技術】従来、化粧品には、皮膚に対する浸透性
や光沢の付与および使用感の向上を目的として、脂肪酸
エステル、シリコーン油などの合成油や植物油、動物油
などの油成分が配合されている。また、医薬品や医薬部
外品には、薬効成分としてサリチル酸グリコール、酢酸
dl−α−トコフェロール、l−メントール、dl−カ
ンフルなどの油成分が配合されている。2. Description of the Related Art Conventionally, cosmetics have been blended with synthetic oils such as fatty acid esters and silicone oils, and oil components such as vegetable oils and animal oils for the purpose of imparting permeability and luster to the skin and improving the feeling of use. . Further, an oil component such as glycol salicylate, dl-α-tocopheryl acetate, 1-menthol, and dl-camphor is blended as a medicinal component in a drug or quasi drug.
【0003】しかしながら、これら油成分とアルコール
成分に液化石油ガスなどの噴射剤を配合してエアゾール
組成物としたばあいには、皮膚に塗布したときに皮膚が
脱脂されるという問題があり、脱脂を防ぐためには水を
配合することが好ましいが、油成分などと水とが分離し
てしまうという問題がある。However, when an aerosol composition is prepared by mixing a propellant such as liquefied petroleum gas with these oil component and alcohol component, there is a problem that the skin is degreased when applied to the skin. In order to prevent this, it is preferable to add water, but there is a problem that oil components and the like are separated from each other.
【0004】このような油成分やアルコール成分と水と
を含有する組成物を均一な状態で安定化させる方法とし
ては、界面活性剤を配合して油中水型エマルジョンや水
中油型エマルジョンにする方法が知られている。As a method for stabilizing a composition containing such an oil component or alcohol component and water in a uniform state, a surfactant is added to form a water-in-oil emulsion or an oil-in-water emulsion. The method is known.
【0005】しかしながら、界面活性剤が配合されたエ
マルジョンは、使用時のべとつきや皮膚に対する刺激が
大きいなどの問題があり、さらにエアゾールとして使用
するために、該エマルジョンに液化石油ガスなどの噴射
剤を配合したエアゾール組成物は、長期間保存すると内
容物が層分離をおこし、使用のたびに前もって充分に振
盪することを必要とすることがあり、とくに医薬品で
は、薬効成分を使用のたびに繰返して同じ量だけを均一
に塗布することが困難であるという問題がある。However, emulsions containing a surfactant have problems such as stickiness during use and great irritation to the skin. Further, in order to use as an aerosol, a propellant such as liquefied petroleum gas is added to the emulsion. The blended aerosol composition may cause the contents to separate into layers when stored for a long period of time, and it may be necessary to sufficiently shake each time before use. There is a problem that it is difficult to apply the same amount uniformly.
【0006】[0006]
【発明が解決しようとする課題】本発明は、前記従来技
術に鑑みてなされたものであり、皮膚の脱脂や皮膚刺激
性がなく、しかも層分離がおこりにくく、使用のたびに
振盪しなくても均一で所望の組成の内容物をそのまま取
り出すことができるエアゾール組成物の製法を提供する
ことを目的とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above-mentioned prior art, and has no degreasing or skin irritation to the skin, moreover does not easily cause layer separation, and does not shake each time it is used. It is also an object of the present invention to provide a method for producing an aerosol composition in which the contents having a uniform and desired composition can be taken out as they are.
【0007】[0007]
【課題を解決するための手段】すなわち、本発明は
(A)油成分、または油成分とアルコール成分30〜85重
量%および(B)水15〜70重量%からなる原液、ならび
に(C)ジメチルエーテルからなり、前記原液とジメチ
ルエーテルとの合計量100 重量部に対する原液の割合を
2〜60重量部、ジメチルエーテルの割合を40〜98重量部
とし、前記(A)成分と前記(B)成分とを混合したの
ち、これに前記(C)成分を混合することを特徴とする
エアゾール組成物の製法に関する。Means for Solving the Problems That is, the present invention relates to (A) an oil component, or a stock solution comprising 30 to 85% by weight of an oil component and an alcohol component and (B) 15 to 70% by weight of water, and (C) dimethyl ether. The ratio of the stock solution is 2 to 60 parts by weight and the ratio of dimethyl ether is 40 to 98 parts by weight with respect to 100 parts by weight of the total amount of the stock solution and dimethyl ether, and the components (A) and (B) are mixed. Then, the present invention relates to a method for producing an aerosol composition, which comprises mixing the component (C).
【0008】[0008]
【作用および実施例】本発明の製法によれば、特定の配
合割合の油成分、または油成分とアルコール成分、およ
び水からなる原液にジメチルエーテルを特定の配合割合
で混合することにより、原液段階では相互に層分離する
油成分、または油成分とアルコール成分と、水とがジメ
チルエーテル中に均質に溶解したエアゾール組成物がえ
られる。According to the production method of the present invention, by mixing dimethyl ether at a specific blending ratio with a stock solution consisting of an oil component in a specific blending ratio, or an oil component and an alcohol component, and water, a stock solution stage is obtained. An aerosol composition is obtained in which an oil component that is layer-separated from each other, or an oil component and an alcohol component, and water are homogeneously dissolved in dimethyl ether.
【0009】本発明のエアゾール組成物の製法において
は、以下に説明する(A)成分および(B)成分からな
る原液が用いられる。In the method for producing the aerosol composition of the present invention, a stock solution comprising the components (A) and (B) described below is used.
【0010】前記(A)成分は油成分、または油成分と
アルコール成分である。The component (A) is an oil component or an oil component and an alcohol component.
【0011】前記油成分は、皮膚に対する浸透性や光沢
を付与し、使用感を向上させ、薬理作用を付与するため
の成分であり、このような目的のために用いることがで
きるものであればとくに限定がないが、かかる油成分が
脂肪酸エステル、シリコーン油、油溶性薬理活性物質、
植物油および動物油からなる群より選ばれた少なくとも
1種であることが好ましい。The oil component is a component for imparting skin permeability and luster, improving the feeling of use, and imparting a pharmacological action, and as long as it can be used for such purpose. Although not particularly limited, such oil components include fatty acid esters, silicone oils, oil-soluble pharmacologically active substances,
It is preferably at least one selected from the group consisting of vegetable oils and animal oils.
【0012】前記油成分の具体例としては、たとえばミ
リスチン酸イソプロピル、ミリスチン酸ミリスチル、ミ
リスチン酸オクチルドデシル、パルミチン酸イソプロピ
ル、ステアリン酸ブチル、リノール酸エチル、リノール
酸イソプロピル、アジピン酸ジイソプロピル、セバシン
酸ジイソプロピル、セバシン酸ジエチルなどの脂肪酸エ
ステル;メチルフェニルポリシロキサン、オクタメチル
シクロテトラシロキサン、デカメチルシクロペンタシロ
キサンなどのシリコーン油;dl−カンフル、l−メン
トール、サリチル酸グリコール、サリチル酸メチル、酢
酸dl−α−トコフェロール、ユーカリ油、ディート、
リドカイン、クロタミトン、ジフェンヒドラミン、ビタ
ミン油などの油溶性薬理活性物質;オリーブ油、アーモ
ンド油、ホホバ油、落花生油、ヒマシ油、ヤシ油、パー
ム油、サフラワー油、ヒマワリ油、綿実油、アボカド
油、ツバキ油、トウモロコシ油、小麦胚芽油、コメヌカ
油、カカオ脂、ゴマ油、月見草油、紅花油、サザンカ
油、大豆油、ナタネ油、カルナバロウ、マカデミアンナ
ッツ油、杏仁油、グレープシード油などの植物油;ラノ
リンおよびラノリン誘導体、タートル油、ミンク油、ミ
ツロウ、スクワレン、スクワラン、プリスタン、卵黄油
などの動物油などがあげられ、これらは単独でまたは2
種以上を混合して用いられる。Specific examples of the oil component include isopropyl myristate, myristyl myristate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, ethyl linoleate, isopropyl linoleate, diisopropyl adipate, diisopropyl sebacate, Fatty acid esters such as diethyl sebacate; silicone oils such as methylphenylpolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane; dl-camphor, 1-menthol, glycol salicylate, methyl salicylate, dl-α-tocopherol acetate. Eucalyptus oil, diet,
Oil-soluble pharmacologically active substances such as lidocaine, crotamiton, diphenhydramine and vitamin oil; olive oil, almond oil, jojoba oil, peanut oil, castor oil, coconut oil, palm oil, safflower oil, sunflower oil, cottonseed oil, avocado oil, camellia oil , Corn oil, wheat germ oil, rice bran oil, cacao butter, sesame oil, evening primrose oil, safflower oil, southern oil, soybean oil, rapeseed oil, carnauba wax, macadamian nut oil, apricot kernel oil, grape seed oil and other vegetable oils; lanolin and Examples include animal oils such as lanolin derivatives, turtle oil, mink oil, beeswax, squalene, squalane, pristane, and egg yolk oil, which may be used alone or in combination with 2
It is used as a mixture of two or more species.
【0013】前記アルコール成分は、粘度が高い油成分
を希釈し、2種以上の油成分を用いたばあいには、これ
らを均一に混合し、溶解させるための成分であり、この
ような目的のために用いることができるものであればと
くに限定がない。The alcohol component is a component for diluting an oil component having a high viscosity, and when two or more oil components are used, they are uniformly mixed and dissolved. There is no particular limitation as long as it can be used for.
【0014】前記アルコール成分の具体例としては、た
とえばエタノール、イソプロパノールなどがあげられ、
エタノールは通常用いられているものでよく、未変性エ
タノール、各種変性エタノールなどを用いることができ
る。これらは単独でまたは2種以上を混合して用いられ
る。Specific examples of the alcohol component include, for example, ethanol and isopropanol,
Ethanol may be a commonly used one, and undenatured ethanol, various denatured ethanol and the like can be used. These may be used alone or in admixture of two or more.
【0015】また、前記アルコール成分は、水分が多量
に含まれているばあいには、層分離を生じるようになる
ので、その濃度が90%以上、なかんづく95%以上のもの
が好ましい。When the alcohol component contains a large amount of water, layer separation occurs. Therefore, the alcohol component preferably has a concentration of 90% or more, particularly 95% or more.
【0016】(A)成分におけるアルコール成分の配合
量は、油成分 100部(重量部、以下同様)に対して3000
部以下、なかんづく1000部以下であることが好ましい。
かかるアルコール成分の配合量が3000部をこえるばあい
には、油成分を用いたことによる効果が充分に発現され
なくなる傾向がある。The blending amount of the alcohol component in the component (A) is 3000 with respect to 100 parts of the oil component (parts by weight, the same applies hereinafter).
It is preferably not more than 1000 parts, especially not more than 1000 parts.
When the content of the alcohol component exceeds 3000 parts, the effect of using the oil component tends to be insufficiently exhibited.
【0017】(A)成分の原液中の配合量は、30〜85重
量%、好ましくは40〜80重量%である。かかる(A)成
分の配合量が30重量%未満であるばあいには、えられる
エアゾール組成物が分離しやすくなり、また85重量%を
こえるばあいには、エアゾール組成物を皮膚に塗布した
際に皮膚の脱脂がおこりやすくなる。The content of the component (A) in the stock solution is 30 to 85% by weight, preferably 40 to 80% by weight. When the content of the component (A) is less than 30% by weight, the obtained aerosol composition becomes easy to separate, and when it exceeds 85% by weight, the aerosol composition is applied to the skin. When this happens, degreasing of the skin is likely to occur.
【0018】前記(B)成分である水は、エアゾール組
成物を皮膚に塗布した際に皮膚が脱脂されるのを防ぐた
めの成分であり、かかる水にはとくに限定がなく、たと
えば蒸留水、イオン交換水などの精製水などを用いるこ
とができる。The water as the component (B) is a component for preventing degreasing of the skin when the aerosol composition is applied to the skin, and such water is not particularly limited. For example, distilled water, Purified water such as ion-exchanged water can be used.
【0019】(B)成分の原液中の配合量は、15〜70重
量%、好ましくは20〜60重量%である。かかる(B)成
分の配合量が15重量%未満であるばあいには、えられる
エアゾール組成物を皮膚に塗布した際に皮膚の脱脂がお
こりやすくなり、また70重量%をこえるばあいには、エ
アゾール組成物が分離しやすくなる。The content of the component (B) in the stock solution is 15 to 70% by weight, preferably 20 to 60% by weight. When the blending amount of the component (B) is less than 15% by weight, degreasing of the skin is likely to occur when the obtained aerosol composition is applied to the skin, and when it exceeds 70% by weight. The aerosol composition becomes easy to separate.
【0020】本発明で用いられる原液には、これら
(A)成分および(B)成分のほかに、各種有効成分、
溶剤などを用途に応じて本発明の目的が阻害されない範
囲内で適宜選択して用いることができる。The stock solution used in the present invention contains various active ingredients in addition to the components (A) and (B).
A solvent or the like can be appropriately selected and used according to the application within a range not impairing the object of the present invention.
【0021】前記有効成分の具体例としては、たとえば
アストリンゼント有効成分、ヘアスプレー有効成分、ベ
ビーオイル有効成分、爪保護有効成分、制汗有効成分、
ヘアトニック有効成分、アフターシェーブローション有
効成分、ハンドローション有効成分、サンタンローショ
ン有効成分、ボディーローション有効成分、かゆみ止め
有効成分、消炎鎮痛剤有効成分、養毛剤有効成分、殺菌
剤有効成分、香料などがあげられる。Specific examples of the active ingredients include, for example, astringent active ingredients, hair spray active ingredients, baby oil active ingredients, nail protection active ingredients, antiperspirant active ingredients,
Hair tonic active ingredient, after-shave lotion active ingredient, hand lotion active ingredient, suntan lotion active ingredient, body lotion active ingredient, anti-itch active ingredient, anti-inflammatory analgesic active ingredient, hair restorer active ingredient, bactericide active ingredient, fragrance, etc. .
【0022】前記有効成分を用いるばあいの原液中の有
効成分の配合量は、その有効成分の種類に応じて異なる
が、かかる有効成分を配合したことによる効果が充分に
発現されうるように調整することが好ましい。かかる配
合量は、多すぎるばあいには、噴射剤などとの相溶性、
安定性が低下する傾向があるので、好ましくは約15重量
%以下、さらに好ましくは約10重量%以下となるように
調整することが望ましい。When the above-mentioned active ingredient is used, the amount of the active ingredient blended in the stock solution varies depending on the kind of the active ingredient, but it is adjusted so that the effect due to the blending of the active ingredient can be sufficiently exhibited. It is preferable. If the blending amount is too large, compatibility with a propellant and the like,
Since the stability tends to decrease, it is desirable to adjust the concentration to preferably about 15% by weight or less, more preferably about 10% by weight or less.
【0023】前記溶剤の具体例としては、たとえばプロ
ピレングリコール、エチレングリコール、ジエチレング
リコール、トリエチレングリコール、グリセリン、1,
3−ブチレングリコールなどの多価アルコールなどがあ
げられる。Specific examples of the solvent include propylene glycol, ethylene glycol, diethylene glycol, triethylene glycol, glycerin, 1,
Examples include polyhydric alcohols such as 3-butylene glycol.
【0024】前記溶剤を用いるばあいの原液中の溶剤の
配合量は、好ましくは約20重量%以下、さらに好ましく
は約15重量%以下となるように調整することが望まし
い。When the above-mentioned solvent is used, it is desirable to adjust the content of the solvent in the stock solution to be preferably about 20% by weight or less, more preferably about 15% by weight or less.
【0025】本発明において、噴射剤としてジメチルエ
ーテル((C)成分)が用いられる。In the present invention, dimethyl ether ((C) component) is used as a propellant.
【0026】前記原液とジメチルエーテルとの合計量10
0 部に対する原液の割合は、2〜60部、なかんづく10〜
50部とされ、ジメチルエーテルの割合は、40〜98部、な
かんづく50〜90部とされる。原液とジメチルエーテルと
の合計量100 部に対するジメチルエーテルの割合が40部
未満であるばあいには、原液とジメチルエーテルとが二
層に分離してしまい、均一なエアゾール組成物がえられ
なくなり、また98部をこえるばあいには、相対的に原液
の量が少なくなりすぎて本発明の目的を達成することが
できなくなるとともに、ジメチルエーテルの量が相対的
に多くなり、安全性の面で好ましくない。Total amount of the stock solution and dimethyl ether 10
The ratio of undiluted solution to 0 parts is 2-60 parts, especially 10-
The ratio of dimethyl ether is 40 to 98 parts, especially 50 to 90 parts. When the ratio of dimethyl ether to the total amount of the undiluted solution and dimethyl ether is 100 parts is less than 40 parts, the undiluted solution and dimethyl ether are separated into two layers, and a uniform aerosol composition cannot be obtained. If it exceeds, the amount of the undiluted solution becomes too small to achieve the object of the present invention, and the amount of dimethyl ether becomes relatively large, which is not preferable in terms of safety.
【0027】なお、本発明においては、前記ジメチルエ
ーテル以外にも、噴射剤としてF12、F114 、F134 a
などのハイドロフルオロカーボン、液化石油ガス(プロ
パン、i−ブタン、n−ブタンなどの混合物)などを用
いることができる。In the present invention, in addition to the above-mentioned dimethyl ether, F12, F114, F134a as a propellant can be used.
And the like, liquefied petroleum gas (a mixture of propane, i-butane, n-butane, etc.) and the like can be used.
【0028】これらジメチルエーテル以外の噴射剤とし
て用いられる成分は、原液と噴射剤とが二層に分離しな
い範囲で油成分、水、アルコール成分、ジメチルエーテ
ルの一部のかわりに用いることができ、具体的には油成
分、水、アルコール成分、ジメチルエーテルの使用しう
る合計量の20重量%以下、なかんづく10重量%以下で用
いることが、所望の性質を発現しうる組成物をうるため
には好ましい。Components other than these dimethyl ethers used as a propellant can be used in place of the oil component, water, alcohol component and a part of dimethyl ether as long as the undiluted solution and the propellant are not separated into two layers. It is preferable to use 20% by weight or less, especially 10% by weight or less of the total amount of the oil component, water, alcohol component and dimethyl ether that can be used in order to obtain a composition capable of exhibiting desired properties.
【0029】本発明の製法において、原液を構成する
(A)成分と(B)成分とを2工程に分けてエアゾール
用耐圧容器に順次充填してかかる成分を混合したのち、
これに(C)成分である噴射剤を充填して混合すること
によりエアゾール組成物がえられる。In the production method of the present invention, the component (A) and the component (B) constituting the stock solution are divided into two steps, and the aerosol pressure-resistant container is sequentially filled, and the components are mixed.
An aerosol composition is obtained by filling and mixing a propellant which is the component (C) in this.
【0030】前記エアゾール用耐圧容器としては、通常
用いられているものを用いることができ、また前記のよ
うにしてえられるエアゾール組成物の25℃での内圧が2
〜6kg/cm2 ・G 、なかんづく3〜5kg/cm2 ・G とな
るように調整することが好ましい。As the aerosol pressure-resistant container, a conventionally used one can be used, and the aerosol composition obtained as described above has an internal pressure of 2 at 25 ° C.
It is preferable to adjust the pressure so as to be 6 kg / cm 2 · G, especially 3 to 5 kg / cm 2 · G.
【0031】前記(A)成分が油成分とアルコール成分
とからなるばあいには、通常、これらをあらかじめ均一
に混合しておいてから(B)成分と混合すればよい。When the component (A) is composed of an oil component and an alcohol component, it is usually sufficient that they are uniformly mixed in advance and then mixed with the component (B).
【0032】なお、前記有効成分や溶剤を用いるばあい
には、これらは(A)成分または(B)成分中にあらか
じめ添加して混合しておいてもよく、(A)成分と
(B)成分とを混合してから添加して混合してもよい。
また、ジメチルエーテルと、該ジメチルエーテル以外の
噴射剤とを併用するばあいには、該ジメチルエーテル以
外の噴射剤をあらかじめジメチルエーテルと混合してか
ら原液と混合することが好ましい。When the above-mentioned active ingredients and solvents are used, they may be added in advance to the component (A) or the component (B) and mixed, and the components (A) and (B) may be mixed. The components may be mixed and then added and mixed.
When dimethyl ether and a propellant other than dimethyl ether are used in combination, it is preferable that the propellant other than dimethyl ether is mixed with dimethyl ether in advance and then mixed with the stock solution.
【0033】本発明の製法によりえられるエアゾール組
成物は、長期間保存しても均質であり、層分離がおこり
にくく、使用のたびに振盪しなくても均一な組成の内容
物をそのまま取り出すことができ、また皮膚の脱脂や皮
膚刺激性が小さいので、たとえば化粧品、医薬品、医薬
部外品などといった幅広い分野に好適に使用することが
できる。The aerosol composition obtained by the production method of the present invention is homogeneous even when stored for a long period of time, layer separation is unlikely to occur, and the content of a uniform composition can be taken out as it is without shaking each time it is used. In addition, since the degreasing and skin irritation of the skin is small, it can be suitably used in a wide range of fields such as cosmetics, pharmaceuticals, and quasi-drugs.
【0034】つぎに本発明のエアゾール組成物の製法を
実施例に基づいてさらに詳細に説明するが、本発明はか
かる実施例のみに限定されるものではない。Next, the method for producing the aerosol composition of the present invention will be described in more detail based on examples, but the present invention is not limited to these examples.
【0035】実施例1 (A)成分としてミリスチン酸イソプロピル5部および
99%エタノール30部、ならびに(B)成分として精製水
15部を用い、エアゾール用耐圧容器(満注量:200ml )
に、(A)成分、(B)成分の順に充填して混合したの
ち、(C)成分としてジメチルエーテル50部を充填し、
軽く浸盪して溶解させてつや出し用ヘアースプレーとし
てのエアゾール組成物をえた。このときの内圧は25℃で
3.8kg/cm2 ・G に調整した。Example 1 As component (A), 5 parts of isopropyl myristate and
30 parts of 99% ethanol and purified water as component (B)
Using 15 parts, aerosol pressure resistant container (full volume: 200 ml)
Then, the components (A) and (B) are charged in this order and mixed, and then 50 parts of dimethyl ether is added as the component (C).
It was lightly agitated and dissolved to obtain an aerosol composition as a hair spray for polishing. The internal pressure at this time is 25 ° C
Adjusted to 3.8kg / cm 2 · G.
【0036】エアゾール組成物を調製する前の段階の原
液の状態およびえられたエアゾール組成物の調製1日後
の状態を、目視にて外観を観察して調べたところ、原液
の段階では層分離をおこしていたが、えられた組成物に
は層分離が認められず均一な溶液となっていた。また、
この組成物を室温で30日間放置したのち、前記と同様に
して組成物の状態を調べたところ、均一な状態が保たれ
ていた。The state of the stock solution before the preparation of the aerosol composition and the state one day after the preparation of the obtained aerosol composition were visually inspected, and the appearance was examined. However, no layer separation was observed in the obtained composition, and a uniform solution was obtained. Also,
After leaving this composition at room temperature for 30 days, the state of the composition was examined in the same manner as above, and it was found that a uniform state was maintained.
【0037】えられたエアゾール組成物を頭髪に噴霧し
てそのつや出し効果を調べたところ、該エアゾール組成
物を噴霧した部分は、その他の部分と比較してつややか
な髪の状態となり、該エアゾール組成物がすぐれたつや
出し効果を有することがわかった。When the obtained aerosol composition was sprayed on the hair and its glossing effect was examined, the sprayed portion of the aerosol composition had a glossy hair state as compared with the other portions, and the aerosol composition It has been found that the objects have an excellent polish effect.
【0038】また、えられたエアゾール組成物の特性と
して、頭髪に対するなじみ、べたつき感、皮膚の脱脂、
皮膚の刺激について、無作為に抽出した男女50名のパネ
ラーの頭部(頭髪)にエアゾール組成物5gを噴霧し、
各々以下の評価基準にしたがって評価した。The characteristics of the obtained aerosol composition are familiar to the hair, sticky feeling, degreasing of the skin,
For skin irritation, 5 g of the aerosol composition was sprayed on the heads (hair) of 50 randomly selected panelists of men and women,
Each was evaluated according to the following evaluation criteria.
【0039】(評価基準) (イ)頭髪に対するなじみ A:40名以上がなじみがよいと感じた。 B:30〜39名がなじみがよいと感じた。 C:20〜29名がなじみがよいと感じた。 D:10〜19名がなじみがよいと感じた。 E:9名以下しかなじみがよいと感じなかった。(Evaluation Criteria) (a) Familiarity with Hair A: More than 40 people felt that they were familiar. B: 30 to 39 people felt familiar. C: 20 to 29 people felt familiar. D: 10 to 19 people felt familiar. E: Only 9 people or less felt familiar.
【0040】(ロ)べたつき感 A:9名以下がべたつき感があると感じた。 B:10〜19名がべたつき感があると感じた。 C:20〜29名がべたつき感があると感じた。 D:30〜39名がべたつき感があると感じた。 E:40名以上がべたつき感があると感じた。(B) Sticky feeling A: 9 or less people felt that there was sticky feeling. B: 10 to 19 people felt that it was sticky. C: 20 to 29 people felt that it was sticky. D: 30 to 39 people felt that it was sticky. E: More than 40 people felt sticky.
【0041】(ハ)皮膚の脱脂 A:9名以下が皮膚が脱脂されたと感じた。 B:10〜19名が皮膚が脱脂されたと感じた。 C:20〜29名が皮膚が脱脂されたと感じた。 D:30〜39名が皮膚が脱脂されたと感じた。 E:40名以上が皮膚が脱脂されたと感じた。(C) Degreasing of skin A: 9 or less people felt that the skin was degreased. B: 10 to 19 people felt that the skin was degreased. C: 20 to 29 people felt that the skin was degreased. D: 30 to 39 people felt that the skin was degreased. E: More than 40 people felt that the skin was degreased.
【0042】(ニ)皮膚の刺激 A:9名以下が皮膚に刺激を感じた。 B:10〜19名が皮膚に刺激を感じた。 C:20〜29名が皮膚に刺激を感じた。 D:30〜39名が皮膚に刺激を感じた。 E:40名以上が皮膚に刺激を感じた。(D) Skin irritation A: 9 or less people felt irritation on the skin. B: 10 to 19 people felt irritation on the skin. C: 20 to 29 people felt irritation on the skin. D: 30 to 39 people felt irritation on the skin. E: More than 40 people felt irritation on the skin.
【0043】エアゾール組成物を調製する前の段階の原
液の状態およびえられたエアゾール組成物の状態ならび
に各特性のモニターテストの結果を表1に示す。Table 1 shows the state of the stock solution before the preparation of the aerosol composition, the state of the obtained aerosol composition and the results of the monitor test of each property.
【0044】実施例2〜5および比較例1〜4 各成分の配合量を表1に示すように変更したほかは実施
例1と同様にしてエアゾール組成物を調製し、実施例1
と同様にしてエアゾール組成物を調製する前の段階の原
液の状態およびえられたエアゾール組成物の状態を観察
し、また各特性のモニターテストを行なった。その結果
を表1に示す。Examples 2 to 5 and Comparative Examples 1 to 4 An aerosol composition was prepared in the same manner as in Example 1 except that the compounding amounts of the components were changed as shown in Table 1.
Similarly to the above, the state of the stock solution before the preparation of the aerosol composition and the state of the obtained aerosol composition were observed, and a monitor test of each characteristic was performed. The results are shown in Table 1.
【0045】なお、実施例2〜5のエアゾール組成物は
実施例1のものと同様にすぐれたつや出し効果を有する
ものであった。The aerosol compositions of Examples 2 to 5 had the same excellent lustering effect as those of Example 1.
【0046】実施例6 (A)成分としてサリチル酸グリコール 4.5部、l−メ
ントール11部および95%8−アセチル化ショ糖変性エタ
ノール12.5部、ならびに(B)成分として精製水12部を
用い、エアゾール用耐圧容器(満注量: 200ml)に、
(A)成分、(B)成分の順に充填して混合したのち、
(C)成分としてジメチルエーテル60部を充填し、軽く
浸盪して溶解させて消炎鎮痛剤としてのエアゾール組成
物をえた。このときの内圧は25℃で 3.8kg/cm2 ・G に
調整した。Example 6 Using 4.5 parts of glycol salicylate as the component (A), 11 parts of 1-menthol and 12.5 parts of 95% 8-acetylated sucrose denatured ethanol, and 12 parts of purified water as the component (B), for aerosol In a pressure resistant container (full volume: 200 ml),
After filling the components (A) and (B) in this order and mixing,
60 parts of dimethyl ether was charged as the component (C), and the mixture was lightly agitated and dissolved to obtain an aerosol composition as an anti-inflammatory analgesic. The internal pressure at this time was adjusted to 3.8 kg / cm 2 · G at 25 ° C.
【0047】エアゾール組成物を調製する前の段階の原
液の状態およびえられたエアゾール組成物の状態を実施
例1と同様にして観察した。その結果を表2に示す。The state of the stock solution before the preparation of the aerosol composition and the state of the obtained aerosol composition were observed in the same manner as in Example 1. The results are shown in Table 2.
【0048】つぎに、えられたエアゾール組成物を上腕
部の炎症部分に噴霧してその消炎鎮痛効果を調べたとこ
ろ、炎症がおさまり、該エアゾール組成物が消炎鎮痛効
果を有することがわかった。Next, the obtained aerosol composition was sprayed on the inflamed part of the upper arm to examine its anti-inflammatory and analgesic effect. As a result, it was found that the inflammation subsided and the aerosol composition had the anti-inflammatory and analgesic effect.
【0049】また、えられたエアゾール組成物の特性と
して、皮膚に対するなじみ、べたつき感、皮膚の脱脂、
皮膚の刺激について、無作為に抽出した男女50名のパネ
ラーの上腕部にエアゾール組成物5gを噴霧し、各々実
施例1と同様の評価基準(ただし、皮膚に対するなじみ
の評価基準は前記頭髪に対するなじみの評価基準と同
様)にしたがって評価した。その結果を表2に示す。The characteristics of the obtained aerosol composition are familiar to the skin, sticky feeling, degreasing of the skin,
For skin irritation, 5 g of the aerosol composition was sprayed onto the upper arm of 50 randomly selected male and female panelists, and the same evaluation criteria as in Example 1 were used (however, the evaluation criteria for familiarity with the skin are familiar with the above hair). (Same as the evaluation standard of 1). The results are shown in Table 2.
【0050】実施例7 各成分の配合量を表2に示すように変更したほかは実施
例6と同様にしてエアゾール組成物を調製し、実施例6
と同様にしてエアゾール組成物を調製する前の段階の原
液の状態およびえられたエアゾール組成物の状態を観察
し、また各特性のモニターテストを行なった。その結果
を表2に示す。Example 7 An aerosol composition was prepared in the same manner as in Example 6 except that the compounding amounts of the respective components were changed as shown in Table 2.
Similarly to the above, the state of the stock solution before the preparation of the aerosol composition and the state of the obtained aerosol composition were observed, and a monitor test of each characteristic was performed. The results are shown in Table 2.
【0051】なお、かかるエアゾール組成物は実施例6
のものと同様に消炎鎮痛効果を有するものであった。The aerosol composition of Example 6 was prepared.
It also had an anti-inflammatory and analgesic effect.
【0052】[0052]
【表1】 [Table 1]
【0053】[0053]
【表2】 [Table 2]
【0054】表1および表2に示した結果から明らかな
ように、本発明の製法によりえられたエアゾール組成物
は、長期間保存したばあいであっても層分離などの発生
がなく、なじみがよく、べたつき感、皮膚の脱脂、皮膚
の刺激がないなど、種々の物性にすぐれたものであるこ
とがわかる。As is clear from the results shown in Tables 1 and 2, the aerosol composition obtained by the production method of the present invention does not cause layer separation even when it is stored for a long period of time, and is well known. It is clear that it has excellent physical properties such as a sticky feeling, no degreasing of the skin, and no skin irritation.
【0055】[0055]
【発明の効果】本発明の製法によれば、長期間保存して
も均質であり、層分離がおこりにくく、使用のたびに振
盪しなくても均一な組成の内容物をそのまま取り出すこ
とができ、皮膚の脱脂や皮膚刺激性がない、たとえば化
粧品、医薬品、医薬部外品などといった幅広い分野に好
適に使用することができるエアゾール組成物をうること
ができる。EFFECTS OF THE INVENTION According to the production method of the present invention, the contents are homogeneous even when stored for a long period of time, layer separation hardly occurs, and the contents having a uniform composition can be taken out as they are without shaking each time they are used. It is possible to obtain an aerosol composition which has no skin degreasing or skin irritation and can be suitably used in a wide range of fields such as cosmetics, pharmaceuticals, and quasi drugs.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/06 8615−4C 7/48 9051−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location A61K 7/06 8615-4C 7/48 9051-4C
Claims (3)
ル成分30〜85重量%および(B)水15〜70重量%からな
る原液、ならびに(C)ジメチルエーテルからなり、前
記原液とジメチルエーテルとの合計量100 重量部に対す
る原液の割合を2〜60重量部、ジメチルエーテルの割合
を40〜98重量部とし、前記(A)成分と前記(B)成分
とを混合したのち、これに前記(C)成分を混合するこ
とを特徴とするエアゾール組成物の製法。1. A stock solution comprising (A) an oil component, or 30 to 85% by weight of an oil component and an alcohol component and (B) 15 to 70% by weight of water, and (C) dimethyl ether. The ratio of the undiluted solution to the total amount of 100 parts by weight is 2 to 60 parts by weight, the ratio of dimethyl ether is 40 to 98 parts by weight, and the component (A) and the component (B) are mixed, and then the component (C) is added thereto. A method for producing an aerosol composition, which comprises mixing the components.
油、油溶性薬理活性物質、植物油および動物油からなる
群より選ばれた少なくとも1種である請求項1記載のエ
アゾール組成物の製法。2. The method for producing an aerosol composition according to claim 1, wherein the oil component is at least one selected from the group consisting of fatty acid esters, silicone oils, oil-soluble pharmacologically active substances, vegetable oils and animal oils.
たはイソプロパノールである請求項1または2記載のエ
アゾール組成物の製法。3. The method for producing an aerosol composition according to claim 1, wherein the alcohol component is ethanol and / or isopropanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24638392A JP3203350B2 (en) | 1992-09-16 | 1992-09-16 | Method for producing aerosol composition for human body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24638392A JP3203350B2 (en) | 1992-09-16 | 1992-09-16 | Method for producing aerosol composition for human body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0692841A true JPH0692841A (en) | 1994-04-05 |
| JP3203350B2 JP3203350B2 (en) | 2001-08-27 |
Family
ID=17147726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24638392A Expired - Fee Related JP3203350B2 (en) | 1992-09-16 | 1992-09-16 | Method for producing aerosol composition for human body |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3203350B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002501523A (en) * | 1997-05-28 | 2002-01-15 | ザ、プロクター、エンド、ギャンブル、カンパニー | Hairspray composition containing silicone block copolymer |
| EP1249482A4 (en) * | 1999-10-01 | 2006-04-05 | Daizo Co Ltd | Aerosol composition |
-
1992
- 1992-09-16 JP JP24638392A patent/JP3203350B2/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002501523A (en) * | 1997-05-28 | 2002-01-15 | ザ、プロクター、エンド、ギャンブル、カンパニー | Hairspray composition containing silicone block copolymer |
| EP1249482A4 (en) * | 1999-10-01 | 2006-04-05 | Daizo Co Ltd | Aerosol composition |
| US7226579B1 (en) | 1999-10-01 | 2007-06-05 | Daizo Co., Ltd. | Aerosol composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3203350B2 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3657395B2 (en) | Composition for external use | |
| CA1278521C (en) | Composition for personal care product comprising alkoxylated fatty alcohol and polysiloxane | |
| EP1365742B1 (en) | Anhydrous cosmetic or pharmaceutical two-phase compositions comprising a nonaqueous hydrophilic external phase, an internal oil phase and a gellant | |
| EP3283053B1 (en) | Multi-layered cosmetic composition | |
| EP0047804A1 (en) | Water-in-oil emulsions and process for preparing same | |
| JP2008504259A (en) | Pharmaceutically elegant topical anhydrous aerosol foam | |
| JP3161869B2 (en) | Water-in-oil aerosol composition and process for producing the same | |
| JP2002500672A (en) | Wax-based products containing water | |
| CN1845720B (en) | Concentrated and diluted stable oil-in-water emulsion | |
| JP2016531948A (en) | Composition | |
| JPS597106A (en) | Emulsifiable composition | |
| KR20230060355A (en) | A two-layer cosmetic composition to which the temporary emulsification effect of natural fermented products is applied | |
| JPS61204109A (en) | Emulsion-type composition for external use | |
| JP4468797B2 (en) | Water-in-oil emulsified cosmetic | |
| AU718789B2 (en) | Formulations for topical use | |
| JPH0692841A (en) | Production of aerosol composition | |
| JP3079178B2 (en) | Aerosol composition | |
| JP2865867B2 (en) | Topical composition containing penciclovir | |
| KR100722677B1 (en) | High water-in-oil emulsified cosmetic composition | |
| JP7449692B2 (en) | Oil-based external composition | |
| JPH05503695A (en) | pharmaceutical formulations | |
| JPS62175414A (en) | Emulsion cosmetic | |
| JPH01294615A (en) | Two layer type cosmetic | |
| JP2522803B2 (en) | Cosmetics | |
| JPH0632710A (en) | Skin external preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20120629 |
|
| LAPS | Cancellation because of no payment of annual fees |